Manufacturer advises caution when dispensing Amoxicillin over missing text on some patient information leaflets


Facebook
Twitter
LinkedIn

By Hiba Mahamadi
Freelance journalist

05 Feb 2019

Pharmacists have been urged caution when dispensing the drug Amoxicillin by manufacturer Accord.

The class 4 drug alert has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for Amoxicillin 500mg capsules. The relevant batch numbers are MP18062, MP18063, and MP18064, distributed in October last year.

Accord Healthcare Limited said important information about potentially life-threatening side effects was not added to the patient information leaflet for some batches.

Community pharmacy teams dispensing this drug have been asked to remove the patient information leaflet and provide a copy of the correct version which can be downloaded here.  

They have also been advised to check the Marketing Authorisation Holder and batch number. 

Any patients who have noticed any symptoms have been asked to seek immediate medical advice.

Facebook
Twitter
LinkedIn